BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 18814181)

  • 41. Impact of transgenic overexpression of SH2-containing inositol 5'-phosphatase 2 on glucose metabolism and insulin signaling in mice.
    Kagawa S; Soeda Y; Ishihara H; Oya T; Sasahara M; Yaguchi S; Oshita R; Wada T; Tsuneki H; Sasaoka T
    Endocrinology; 2008 Feb; 149(2):642-50. PubMed ID: 18039790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling.
    Wang Y; Keogh RJ; Hunter MG; Mitchell CA; Frey RS; Javaid K; Malik AB; Schurmans S; Tridandapani S; Marsh CB
    J Immunol; 2004 Dec; 173(11):6820-30. PubMed ID: 15557176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
    McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
    Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-4 inhibits platelet-derived growth factor-induced preadipocyte proliferation.
    Hua K; Deng J; Harp JB
    Cytokine; 2004 Jan; 25(2):61-7. PubMed ID: 14693161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation.
    Matei D; Chang DD; Jeng MH
    Clin Cancer Res; 2004 Jan; 10(2):681-90. PubMed ID: 14760091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of platelet-derived growth factor receptor tyrosine kinase and downstream signaling pathways by Compound C.
    Kwon HJ; Kim GE; Lee YT; Jeong MS; Kang I; Yang D; Yeo EJ
    Cell Signal; 2013 Apr; 25(4):883-97. PubMed ID: 23277201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma.
    Kim R; Emi M; Arihiro K; Tanabe K; Uchida Y; Toge T
    Cancer; 2005 May; 103(9):1800-9. PubMed ID: 15786421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
    Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
    Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
    Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein.
    Habib T; Hejna JA; Moses RE; Decker SJ
    J Biol Chem; 1998 Jul; 273(29):18605-9. PubMed ID: 9660833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
    Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
    Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
    Biswas SK; Zhao Y; Sandirasegarane L
    Mol Vis; 2009 Aug; 15():1599-610. PubMed ID: 19693287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.
    McGary EC; Onn A; Mills L; Heimberger A; Eton O; Thomas GW; Shtivelband M; Bar-Eli M
    J Invest Dermatol; 2004 Feb; 122(2):400-5. PubMed ID: 15009722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.
    De Schutter J; Guillabert A; Imbault V; Degraef C; Erneux C; Communi D; Pirson I
    J Biol Chem; 2009 Dec; 284(52):36062-36076. PubMed ID: 19880507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PDGF BB induces VEGF secretion in ovarian cancer.
    Matei D; Kelich S; Cao L; Menning N; Emerson RE; Rao J; Jeng MH; Sledge GW
    Cancer Biol Ther; 2007 Dec; 6(12):1951-9. PubMed ID: 18075302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes: contribution of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-bisphosphate.
    Gagnon A; Chen CS; Sorisky A
    Diabetes; 1999 Apr; 48(4):691-8. PubMed ID: 10102683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells.
    Pesesse X; Dewaste V; De Smedt F; Laffargue M; Giuriato S; Moreau C; Payrastre B; Erneux C
    J Biol Chem; 2001 Jul; 276(30):28348-55. PubMed ID: 11349134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
    Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
    Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytes.
    Park SJ; Choe YG; Kim JH; Chang KT; Lee HS; Lee DS
    Food Chem Toxicol; 2016 Jul; 93():5-12. PubMed ID: 27117918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.